1232 Evaluation of HER2 expression in low grade serous carcinoma of the ovary in the antibody-drug c...
1232 Evaluation of HER2 expression in low grade serous carcinoma of the ovary in the antibody-drug conjugate era
About this item
Full title
Author / Creator
Publisher
Kidlington: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
Introduction/BackgroundLow grade serous carcinoma (LGSC) is a subtype of ovarian cancer characterized by chemoresistance and a slow growth rate. Advances in HER2-targeted antibody drug conjugates (ADCs) have demonstrated efficacy in a variety of cancers. However, the significance of HER2 expression in LGSC, especially at low and ultralow levels, re...
Alternative Titles
Full title
1232 Evaluation of HER2 expression in low grade serous carcinoma of the ovary in the antibody-drug conjugate era
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2954871089
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2954871089
Other Identifiers
ISSN
1048-891X
E-ISSN
1525-1438
DOI
10.1136/ijgc-2024-ESGO.811
